We’re commercializing and developing new breakthrough sensor technologies that can detect tumors and lesions instantly at the point of care, without requiring expert interpretation, virtually in any setting and without any pain or radiation.
breakthrough products designed for massive scale across B2B & B2C markets.
examined and help diagnose 200+ cancer cases
Global Agreement in April 21 to market & scale iBreastExam
since 2018; from 750 devices and 1.5M scans
with regulatory approvals & distribution channels
ACOG TV, ACOG 2021 (American College of Obstetricians and Gynecologists Annual Meeting)
Innovative Health Technology
World Health Organization, Compendium of innovative health technologies for low-resource settings
Interested to invest? Let's go!
USA | India | Malaysia
Backers & Partners
Enabling our Vision
Co-Founder & CEO
Co-Founder & CTO
Dreams in Action
UE LifeSciences Inc. Copyright © 2021 | Terms & Conditions